138 related articles for article (PubMed ID: 23460288)
1. New renin inhibitor VTP-27999 alters renin immunoreactivity and does not unfold prorenin.
Krop M; Lu X; Verdonk K; Schalekamp MA; van Gool JM; McKeever BM; Gregg R; Danser AH
Hypertension; 2013 May; 61(5):1075-82. PubMed ID: 23460288
[TBL] [Abstract][Full Text] [Related]
2. Renin inhibitor VTP-27999 differs from aliskiren: focus on their intracellular accumulation and the (pro)renin receptor.
Lu X; Krop M; Batenburg WW; Musterd-Bhaggoe UM; Garrelds IM; Danser AH
J Hypertens; 2014 Jun; 32(6):1255-63. PubMed ID: 24637873
[TBL] [Abstract][Full Text] [Related]
3. Maximum renal responses to renin inhibition in healthy study participants: VTP-27999 versus aliskiren.
Barkoudah E; van Thiel BS; Fisher ND; Gregg RA; Danser AH; Moukarbel GV; Hollenberg NK
J Hypertens; 2016 May; 34(5):935-41. PubMed ID: 26882043
[TBL] [Abstract][Full Text] [Related]
4. Multiple ascending dose study with the new renin inhibitor VTP-27999: nephrocentric consequences of too much renin inhibition.
Balcarek J; Sevá Pessôa B; Bryson C; Azizi M; Ménard J; Garrelds IM; McGeehan G; Reeves RA; Griffith SG; Danser AH; Gregg R
Hypertension; 2014 May; 63(5):942-50. PubMed ID: 24470465
[TBL] [Abstract][Full Text] [Related]
5. Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide.
Feldt S; Batenburg WW; Mazak I; Maschke U; Wellner M; Kvakan H; Dechend R; Fiebeler A; Burckle C; Contrepas A; Jan Danser AH; Bader M; Nguyen G; Luft FC; Muller DN
Hypertension; 2008 Mar; 51(3):682-8. PubMed ID: 18212269
[TBL] [Abstract][Full Text] [Related]
6. Aliskiren-binding increases the half life of renin and prorenin in rat aortic vascular smooth muscle cells.
Batenburg WW; de Bruin RJ; van Gool JM; Müller DN; Bader M; Nguyen G; Danser AH
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1151-7. PubMed ID: 18388329
[TBL] [Abstract][Full Text] [Related]
7. Aliskiren accumulates in Renin secretory granules and binds plasma prorenin.
Krop M; Garrelds IM; de Bruin RJ; van Gool JM; Fisher ND; Hollenberg NK; Jan Danser AH
Hypertension; 2008 Dec; 52(6):1076-83. PubMed ID: 18981317
[TBL] [Abstract][Full Text] [Related]
8. Conformational changes in prorenin during renin inhibition in vitro and in vivo.
Ménard J; Guyene TT; Peyrard S; Azizi M
J Hypertens; 2006 Mar; 24(3):529-34. PubMed ID: 16467656
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a direct prorenin assay making use of a monoclonal antibody directed against residues 32-39 of the prosegment.
Krop M; van Gool JM; Day D; Hollenberg NK; Jan Danser AH
J Hypertens; 2011 Nov; 29(11):2138-46. PubMed ID: 21881521
[TBL] [Abstract][Full Text] [Related]
10. Prorenin engages the (pro)renin receptor like renin and both ligand activities are unopposed by aliskiren.
Schefe JH; Neumann C; Goebel M; Danser J; Kirsch S; Gust R; Kintscher U; Unger T; Funke-Kaiser H
J Hypertens; 2008 Sep; 26(9):1787-94. PubMed ID: 18698213
[TBL] [Abstract][Full Text] [Related]
11. Aliskiren binds to renin and prorenin bound to (pro)renin receptor in vitro.
Biswas KB; Nabi AH; Arai Y; Nakagawa T; Ebihara A; Ichihara A; Watanabe T; Inagami T; Suzuki F
Hypertens Res; 2010 Oct; 33(10):1053-9. PubMed ID: 20664543
[TBL] [Abstract][Full Text] [Related]
12. Combined renin inhibition/(pro)renin receptor blockade in diabetic retinopathy--a study in transgenic (mREN2)27 rats.
Batenburg WW; Verma A; Wang Y; Zhu P; van den Heuvel M; van Veghel R; Danser AH; Li Q
PLoS One; 2014; 9(6):e100954. PubMed ID: 24968134
[TBL] [Abstract][Full Text] [Related]
13. Megalin: A Novel Endocytic Receptor for Prorenin and Renin.
Sun Y; Goes Martini A; Janssen MJ; Garrelds IM; Masereeuw R; Lu X; Danser AHJ
Hypertension; 2020 May; 75(5):1242-1250. PubMed ID: 32200675
[TBL] [Abstract][Full Text] [Related]
14. Do prorenin-synthesizing cells release active, 'open' prorenin?
Martini AG; Krop M; Saleh L; Garrelds IM; Danser AH
J Hypertens; 2017 Feb; 35(2):330-337. PubMed ID: 28005703
[TBL] [Abstract][Full Text] [Related]
15. Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats.
Feldman DL; Jin L; Xuan H; Contrepas A; Zhou Y; Webb RL; Mueller DN; Feldt S; Cumin F; Maniara W; Persohn E; Schuetz H; Jan Danser AH; Nguyen G
Hypertension; 2008 Jul; 52(1):130-6. PubMed ID: 18490518
[TBL] [Abstract][Full Text] [Related]
16. [Renin, prorenin, and the direct renin inhibitor aliskiren].
Slabý A; Zák A
Cas Lek Cesk; 2010; 149(2):55-60. PubMed ID: 20662466
[TBL] [Abstract][Full Text] [Related]
17. The putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling.
Feldt S; Maschke U; Dechend R; Luft FC; Muller DN
J Am Soc Nephrol; 2008 Apr; 19(4):743-8. PubMed ID: 18235083
[TBL] [Abstract][Full Text] [Related]
18. Aliskiren inhibits prorenin-induced human aortic smooth muscle cell migration.
Ferri N; Panariti F; Ricci C; Maiocchi G; Corsini A
J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):284-91. PubMed ID: 25070349
[TBL] [Abstract][Full Text] [Related]
19. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
[TBL] [Abstract][Full Text] [Related]
20. Renin inhibition in hypertension.
Gradman AH; Kad R
J Am Coll Cardiol; 2008 Feb; 51(5):519-28. PubMed ID: 18237679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
